All Articles

Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)

Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1

Copper and liver fibrosis in MASLD: the two-edged sword of copper deficiency and toxicity

Role of skin enzymes in metabolism of topical drugs

Dysregulation of sphingolipid metabolism in liver fibrosis

From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction

Metabolic bariatric surgery, alcohol misuse and liver cirrhosis: a narrative review

Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis

Editorial - Reflecting on three years of M&TOD - Where we are and where we are going

Evaluation of weight loss and quality of life in long-term post-bariatric surgery

Prevention and control of risk factors in metabolic and alcohol-associated steatotic liver disease

Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects

Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge

Obesity and diabetes in heart disease in women

Lower hepatic CBS and PEMT expression in advanced NAFLD: inferencing strategies to lower homocysteine with a mathematical model

Could controversies in the arena of fatty liver disease be a potential gate for the democratization of science?

Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways

Diabetes mellitus and heart disease